TWST — Twist Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- $2.39bn
- $2.12bn
- $312.97m
- 74
- 15
- 77
- 55
Annual cashflow statement for Twist Bioscience, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -140 | -152 | -218 | -205 | -209 |
| Depreciation | |||||
| Non-Cash Items | 16.2 | 39.5 | 82.3 | 33.8 | 97.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -25.2 | -9.38 | -5.36 | -1.01 | 15.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -142 | -112 | -124 | -142 | -64.1 |
| Capital Expenditures | -9.87 | -27.1 | -102 | -27.8 | -5.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -105 | 183 | -131 | 78.4 | 2 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -115 | 156 | -233 | 50.6 | -3.07 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 304 | 329 | 271 | 0.911 | 6.89 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 46.8 | 373 | -87.1 | -91 | -60.1 |